Astria Therapeutics IncNASDAQ:ATXS
- LAST PRICE11.9300
- TODAY'S CHANGE (%)-0.0200 (-0.1674%)
- Bid / Lots9.1800/ 3
- Ask / Lots12.4400/ 1
- Open / Previous Close12.0700 / 11.9500
- Day Range
- 52 Week Range
- Volume262,293
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATXS |
|---|---|---|
| 09:32 ET | 2740 | 12.07 |
| 09:34 ET | 463 | 11.985 |
| 09:36 ET | 410 | 12.155 |
| 09:38 ET | 100 | 12.165 |
| 09:39 ET | 100 | 12.1 |
| 09:41 ET | 600 | 12.18 |
| 09:43 ET | 3400 | 12.195 |
| 09:45 ET | 200 | 12.23 |
| 09:48 ET | 4951 | 12.265 |
| 09:50 ET | 1569 | 12.2999 |
| 09:52 ET | 2100 | 12.21 |
| 09:57 ET | 867 | 12.23 |
| 10:01 ET | 7200 | 12.13 |
| 10:03 ET | 200 | 12.155 |
| 10:06 ET | 100 | 12.155 |
| 10:08 ET | 300 | 12.07 |
| 10:10 ET | 500 | 12.07 |
| 10:14 ET | 547 | 12 |
| 10:17 ET | 900 | 12 |
| 10:19 ET | 208 | 11.99 |
| 10:32 ET | 478 | 11.9 |
| 10:35 ET | 479 | 11.89 |
| 10:37 ET | 900 | 11.92 |
| 10:39 ET | 1120 | 11.955 |
| 10:42 ET | 100 | 11.98 |
| 10:44 ET | 613 | 11.9933 |
| 10:48 ET | 200 | 12.04 |
| 10:50 ET | 2100 | 12.04 |
| 10:51 ET | 100 | 12.05 |
| 10:53 ET | 200 | 12.06 |
| 10:55 ET | 615 | 12.065 |
| 10:57 ET | 600 | 12.09 |
| 11:00 ET | 1256 | 12.095 |
| 11:02 ET | 840 | 12.07 |
| 11:04 ET | 600 | 12.035 |
| 11:09 ET | 909 | 12.07 |
| 11:15 ET | 800 | 12.02 |
| 11:18 ET | 100 | 11.99 |
| 11:26 ET | 955 | 12.03 |
| 11:27 ET | 100 | 12.05 |
| 11:29 ET | 200 | 12.06 |
| 11:31 ET | 100 | 12.07 |
| 11:36 ET | 100 | 12.045 |
| 11:38 ET | 200 | 12.045 |
| 11:40 ET | 300 | 12.07 |
| 11:42 ET | 200 | 12.06 |
| 11:44 ET | 100 | 12.08 |
| 11:45 ET | 100 | 12.09 |
| 11:51 ET | 200 | 12.09 |
| 11:54 ET | 100 | 12.08 |
| 11:56 ET | 800 | 12.02 |
| 11:58 ET | 100 | 12.015 |
| 12:00 ET | 607 | 12.015 |
| 12:02 ET | 400 | 12 |
| 12:03 ET | 100 | 12.02 |
| 12:05 ET | 200 | 12.03 |
| 12:09 ET | 100 | 12.04 |
| 12:12 ET | 700 | 12.02 |
| 12:14 ET | 300 | 12 |
| 12:21 ET | 301 | 11.99 |
| 12:30 ET | 100 | 12 |
| 12:32 ET | 100 | 11.98 |
| 12:34 ET | 1004 | 11.975 |
| 12:39 ET | 200 | 11.95 |
| 12:43 ET | 1381 | 12.02 |
| 12:48 ET | 100 | 12.04 |
| 12:50 ET | 636 | 12.025 |
| 12:52 ET | 497 | 12.06 |
| 12:54 ET | 600 | 12.05 |
| 12:56 ET | 500 | 12.02 |
| 12:57 ET | 100 | 12 |
| 12:59 ET | 100 | 12.01 |
| 01:01 ET | 100 | 12.01 |
| 01:08 ET | 100 | 12.03 |
| 01:10 ET | 200 | 12.03 |
| 01:12 ET | 408 | 12.015 |
| 01:17 ET | 300 | 12.04 |
| 01:19 ET | 150 | 11.9975 |
| 01:21 ET | 100 | 12.04 |
| 01:24 ET | 200 | 12.015 |
| 01:26 ET | 300 | 12.04 |
| 01:28 ET | 100 | 12.04 |
| 01:30 ET | 300 | 12.03 |
| 01:33 ET | 1100 | 12.02 |
| 01:35 ET | 750 | 11.95 |
| 01:37 ET | 100 | 11.94 |
| 01:42 ET | 600 | 11.97 |
| 01:46 ET | 800 | 12.03 |
| 01:48 ET | 300 | 12.05 |
| 01:50 ET | 200 | 12.05 |
| 01:51 ET | 100 | 12.04 |
| 01:53 ET | 100 | 12.04 |
| 01:55 ET | 1600 | 12.05 |
| 01:57 ET | 100 | 12.05 |
| 02:00 ET | 100 | 12.05 |
| 02:02 ET | 1500 | 12.03 |
| 02:04 ET | 600 | 12.03 |
| 02:06 ET | 623 | 12.01 |
| 02:13 ET | 311 | 12.04 |
| 02:15 ET | 1039 | 12.02 |
| 02:20 ET | 500 | 12.02 |
| 02:22 ET | 1000 | 12.005 |
| 02:24 ET | 100 | 12.005 |
| 02:26 ET | 500 | 12.03 |
| 02:27 ET | 560 | 12.03 |
| 02:29 ET | 100 | 12.02 |
| 02:31 ET | 2724 | 11.98 |
| 02:33 ET | 100 | 11.98 |
| 02:36 ET | 200 | 11.98 |
| 02:38 ET | 444 | 11.96 |
| 02:42 ET | 347 | 11.93 |
| 02:44 ET | 500 | 11.89 |
| 02:45 ET | 2132 | 11.92 |
| 02:47 ET | 300 | 11.95 |
| 02:51 ET | 991 | 11.95 |
| 02:54 ET | 100 | 11.97 |
| 02:56 ET | 400 | 11.95 |
| 02:58 ET | 700 | 11.95 |
| 03:02 ET | 1033 | 11.89 |
| 03:05 ET | 300 | 11.89 |
| 03:07 ET | 100 | 11.9 |
| 03:09 ET | 400 | 11.905 |
| 03:12 ET | 16590 | 11.825 |
| 03:14 ET | 300 | 11.83 |
| 03:16 ET | 3757 | 11.83 |
| 03:18 ET | 200 | 11.83 |
| 03:20 ET | 481 | 11.83 |
| 03:21 ET | 881 | 11.8 |
| 03:23 ET | 300 | 11.79 |
| 03:25 ET | 723 | 11.81 |
| 03:27 ET | 1535 | 11.845 |
| 03:32 ET | 100 | 11.87 |
| 03:34 ET | 414 | 11.87 |
| 03:36 ET | 2355 | 11.86 |
| 03:39 ET | 100 | 11.87 |
| 03:41 ET | 1100 | 11.91 |
| 03:43 ET | 1400 | 11.91 |
| 03:45 ET | 598 | 11.92 |
| 03:48 ET | 1087 | 11.925 |
| 03:50 ET | 3217 | 11.88 |
| 03:52 ET | 1920 | 11.94 |
| 03:54 ET | 3923 | 11.93 |
| 03:56 ET | 3616 | 11.949 |
| 03:57 ET | 3949 | 11.945 |
| 03:59 ET | 72388 | 11.93 |
Jul 2, 2024
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:10PM ET on Tuesday Jul 02, 2024 by Dow Jones
4:10PM ET on Tuesday Jul 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Astria Therapeutics Inc | 656.2M | -5.1x | --- |
Phathom Pharmaceuticals Inc | 660.3M | -2.7x | --- |
Alumis Inc | 666.2M | -3.8x | --- |
ACELYRIN Inc | 666.5M | -2.7x | --- |
Mineralys Therapeutics Inc | 668.8M | -6.2x | --- |
Celcuity Inc | 672.2M | -6.7x | --- |
Company Information
Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. The Company's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Its second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis (AD). The Company owns two patent families directed to STAR-0215. The first patent family is directed to the composition of matter of its product candidate STAR-0215 and its use in treating various plasma kallikrein associated disorders including HAE. In the second patent family, the Company owns one International (PCT) patent application directed to methods of treating various plasma-kallikrein associated disorders, including HAE, with specific dosing regimens of the STAR-0215 antibody.
Contact Information
- Headquarters
- 22 Boston Wharf Road, 10Th FloorBOSTON, MA, United States 02210
- Phone
- 617-349-1971
- Fax
- 617-273-2637
Executives
- Independent Chairman of the Board
- Kenneth Bate
- President, Chief Executive Officer, Co-Founder, Principal Financial Officer, Director
- Jill Milne
- Chief Financial Officer
- Noah Clauser
- Chief Legal Officer
- Benjamin Harshbarger
- Chief Commercial Officer
- Andrew Komjathy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $656.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 54.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.69 |
EPS | $-2.32 |
Book Value | $5.92 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
